Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Nataliya Trunova"'
Autor:
Agnish Dey, Matthew Austin, Harriet M. Kluger, Nataliya Trunova, Helen Mann, Norah Shire, Claire Morgan, Diansong Zhou, Ganesh M. Mugundu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
PurposeImmune-mediated adverse events (imAEs) may be associated with response to immune checkpoint inhibitors. We assessed the relationship between imAE development and efficacy in metastatic non-small-cell lung cancer patients treated with durvaluma
Externí odkaz:
https://doaj.org/article/a2a28e63aa1c4c5786506e866b074402
Autor:
Charu Aggarwal, Halla Nimeiri, James Chen, Iker Huerga, Leora Horn, Nataliya Trunova, Jyoti Patel
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b813011bedef71dea43baa2d9311f679
https://doi.org/10.1136/jitc-2022-sitc2022.1403
https://doi.org/10.1136/jitc-2022-sitc2022.1403
Autor:
Marina C. Garassino, Julien Mazieres, Martin Reck, Christos Chouaid, Helge Bischoff, Niels Reinmuth, Laura Cove-Smith, Talal Mansy, Diego Cortinovis, Maria R. Migliorino, Angelo Delmonte, José Garcia Sánchez, Luis Enrique Chara Velarde, Reyes Bernabe, Luis Paz-Ares, Ignacio Diaz Perez, Nataliya Trunova, Kayhan Foroutanpour, Corinne Faivre-Finn
On the basis of the findings of the phase 3 PACIFIC trial (NCT02125461), durvalumab is standard of care for patients with stage III, unresectable NSCLC and no disease progression after concurrent chemoradiotherapy (cCRT). Many patients are considered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc6fad6c65ed3b06a5139f97da1aa1d
https://hdl.handle.net/10668/22343
https://hdl.handle.net/10668/22343
Autor:
Ganesh Mugundu, Nataliya Trunova, Agnish Dey, Matthew Austin, Norah Shire, Harriet M. Kluger, Helen Mann, Diansong Zhou
Publikováno v:
Cancer Research. 81:489-489
Background: The association between immune-mediated adverse events (imAEs) occurring after treatment with immunotherapy and patient outcomes is an important clinical question with prognostic relevance. When toxicity arises from anti-PD1/PD-L1, either
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5ef460c5a8fba92daee483a4aee5a5e
https://doi.org/10.1158/1538-7445.am2021-489
https://doi.org/10.1158/1538-7445.am2021-489
Autor:
Michael McCleod, Howard West, Laurent Gressot, Mark A. Socinski, David R. Spigel, Edward S. Kim, Jeanna Knoble, Oscar Juan, Dolores Isla, Amy Ko, Ray D. Page, Cesare Gridelli, Robert M. Jotte, Michael Thomas, Nataliya Trunova, Teng Jin Ong, Daniel Morgensztern
Publikováno v:
Lung Cancer: Targets and Therapy. 8:207-216
Background Longitudinal data on the impact of treatment on quality of life (QoL) in advanced non-small cell lung cancer (NSCLC) are limited. In this palliative setting, treatment that does not deteriorate QoL is key. Here we report longitudinal QoL i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc987a0f3f7f27af7ad4c83cb4e5e6c5
https://doi.org/10.2147/lctt.s138570
https://doi.org/10.2147/lctt.s138570
Autor:
Nataliya Trunova, Alyssa B Klein, Urvi Mujumdar, Elizabeth Lawler, Maria Lowe, Huifen Wang, Victoria Lanzarini, Cathy Emmas
Publikováno v:
Journal of Clinical Oncology. 37:76-76
76 Background: Immunotherapy presents new challenges for effective patient engagement to ensure that irAEs are reported and treated appropriately. This study directly assesses how NSCLC patients in an online community perceived their irAE education a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6263b3e58fef8226f48f2b0bb9c03895
https://doi.org/10.1200/jco.2019.37.8_suppl.76
https://doi.org/10.1200/jco.2019.37.8_suppl.76
Autor:
Ben George, Jonathan W. Goldman, Tianlei Chen, David M. Waterhouse, Nataliya Trunova, Karen Kelly, Peter O'Dwyer
Publikováno v:
Journal of Thoracic Oncology. 12:S1960-S1961
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d3ba900c080de9a088c995123f59be2
https://doi.org/10.1016/j.jtho.2017.09.830
https://doi.org/10.1016/j.jtho.2017.09.830
Autor:
Cesare Gridelli, T. Chen, Michael McCleod, T. Wehler, Nataliya Trunova, Davey B. Daniel, Andrea Ardizzoni, Robert M. Jotte, B. Levy, Oscar Juan, T. Berry, Daniel Morgensztern, Ray D. Page
Publikováno v:
Annals of Oncology. 28:v489-v490
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e26836fb1854553bdbd6bb46e2f5e6eb
https://doi.org/10.1093/annonc/mdx380.070
https://doi.org/10.1093/annonc/mdx380.070
Autor:
Lisa M. Miller Jenkins, Ettore Appella, Nataliya Trunova, Marco Schito, Yaoxing Huang, Cecilia Cheng-Mayer, Lily Tsai, Agegnehu Gettie, Yungtai Lo, Wuze Ren, Silvana Tasca Sina, James Blanchard, Madina Shakirzyanova
Publikováno v:
AIDS. 25:1833-1841
Objective—Development of an effective vaccine or topical compound to prevent HIV transmission remains a major goal for control of the AIDS pandemic. Using a nonhuman primate model of heterosexual HIV-1 transmission, we tested whether a topical micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e52df0f1bd5f7bd85ed133acfa27bde
https://doi.org/10.1097/qad.0b013e32834a1d94
https://doi.org/10.1097/qad.0b013e32834a1d94
Publikováno v:
Journal of Virology. 82:5653-5656
We report here a second case of coreceptor switch in R5 simian-human immunodeficiency virus SF162P3N (SHIV SF162P3N )-infected macaque CA28, supporting the use of this experimental system to examine factors that drive the change in coreceptor prefere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b877e25f010604ab1c87136a79a5e7
https://doi.org/10.1128/jvi.00145-08
https://doi.org/10.1128/jvi.00145-08